Results 81 to 90 of about 27,311 (150)
Genética Molecular das Epidermólises Bolhosas Molecular Genetics of Epidermolysis Bullosa
O estudo das alterações moleculares das epidermólises bolhosas tem contribuído para que se compreenda melhor essas enfermidades. Na epidermólise bolhosa simples a maioria dos casos está associada com alteração nas citoqueratinas basais 5 (gen KRT5) e 14 (
Hiram Larangeira de Almeida Jr
doaj +1 more source
The puzzling effect of disease severity on quality of life in epidermolysis bullosa
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 8, Page e665-e668, August 2026.
Vinzenz Hübl +4 more
wiley +1 more source
This review analyses the mechanism of action and clinical efficacy of a triterpene complex (birch bark extract), the first product for pathogenetic treatment of wounds associated with dystrophic and junctional congenital epidermolysis bullosa ...
Gulnar R. Batpenova +5 more
doaj +1 more source
Prevalence of anemia in patients with epidermolysis bullosa registered in Australia
Background: Anemia is a common complication of epidermolysis bullosa (EB). To date, no extensive data on the prevalence of anemia in EB patients have been well characterized worldwide.
Shelley Ji Eun Hwang, BSc(Med), MBBS(Hons) +4 more
doaj +1 more source
Generalized atrophic benign epidermolysis bullosa
Generalized atrophic benign epidermolysis bullosa (GABEB) is a rare autosomal recessive variant of junctional epidermolysis bullosa. A typical feature in these patients is the cicatricial alopecia resembling male pattern baldness: in this paper we ...
La Placa M. +3 more
core +1 more source
Oral and gastrointestinal manifestations of epidermolysis bullosa.
The mouth, oesophagus, and anus are often involved in dystrophic and junctional epidermolysis bullosa, but the frequency is unknown. Among 246 patients with epidermolysis bullosa, dysphagia developed in 76% of those with recessive dystrophic, in 20% of ...
Mayou, B +9 more
core +1 more source
Treatment of epidermolysis bullosa with human cultured epidermal allografts
Junctional epidermolysis bullosa letalis type Herlitz Pearson is a genetically determined, life-threatening disease. Effective therapy has been lacking to date.
Ramet, José +3 more
core +1 more source
Response to Oral Dapsone in a Patient With Generalised Junctional Epidermolysis Bullosa
Dapsone is a potent antibacterial agent used as a first‐line treatment for leprosy and employed also as an anti‐inflammatory agent. Additionally, dapsone is used for a variety of other cutaneous conditions.
Shiho Mori +2 more
doaj +1 more source
Successful renal transplant in a patient with non-Herlitz junctional epidermolysis bullosa.
Non-Herlitz junctional epidermolysis bullosa (NH-JEB) is a very rare inherited disorder, with an array of complications. We present the case of a 33-year-old patient of Chinese origin, diagnosed with NH-JEB in childhood, who developed severe IgA ...
Heagerty, A +4 more
core +1 more source
Background Epidermolysis bullosa (EB) is a group of rare hereditary diseases, characterized by fragility of the skin and mucous membranes. Epidemiological data on EB in Brazil are scarce.
Chan I. Thien +5 more
doaj +1 more source

